Gates Foundation Sets Sights On Stopping Spread Of Drug-Resistant Malaria

Seattle Times: Gates Foundation battling big new threat in malaria fight
“…With more than $2 billion committed, the [Bill & Melinda Gates Foundation] is the leading private supporter of research into new treatments, vaccines, diagnostic tools, disease mapping, and other weapons to fight malaria. This research should help the foundation press the global community for a renewed attack that could begin about 2020, putting to use new drugs now in the pipeline. As long as the drug-resistant strain spreading in the forests of Myanmar can be contained, that is…” (Dudley, 7/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.